annual shareholders equity:
$880.28M+$531.86M(+152.65%)Summary
- As of today (May 29, 2025), VKTX annual stockholders equity is $880.28 million, with the most recent change of +$531.86 million (+152.65%) on December 31, 2024.
- During the last 3 years, VKTX annual shareholders equity has risen by +$678.39 million (+336.03%).
- VKTX annual shareholders equity is now at all-time high.
Performance
VKTX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$846.92M-$33.36M(-3.79%)Summary
- As of today (May 29, 2025), VKTX quarterly stockholders equity is $846.92 million, with the most recent change of -$33.36 million (-3.79%) on March 31, 2025.
- Over the past year, VKTX quarterly shareholders equity has dropped by -$86.97 million (-9.31%).
- VKTX quarterly shareholders equity is now -9.31% below its all-time high of $933.89 million, reached on March 31, 2024.
Performance
VKTX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VKTX Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +152.7% | -9.3% |
| 3 y3 years | +336.0% | +364.6% |
| 5 y5 years | +217.7% | +215.7% |
VKTX Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +505.7% | -9.3% | +531.7% |
| 5 y | 5-year | at high | +505.7% | -9.3% | +531.7% |
| alltime | all time | at high | +4078.0% | -9.3% | +3142.2% |
VKTX Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $846.92M(-3.8%) |
| Dec 2024 | $880.28M(+152.6%) | $880.28M(-3.4%) |
| Sep 2024 | - | $911.45M(-1.0%) |
| Jun 2024 | - | $920.98M(-1.4%) |
| Mar 2024 | - | $933.89M(+168.0%) |
| Dec 2023 | $348.42M(+139.8%) | $348.42M(-5.4%) |
| Sep 2023 | - | $368.24M(-4.6%) |
| Jun 2023 | - | $386.12M(+188.0%) |
| Mar 2023 | - | $134.06M(-7.7%) |
| Dec 2022 | $145.32M(-28.0%) | $145.32M(-3.9%) |
| Sep 2022 | - | $151.28M(-8.4%) |
| Jun 2022 | - | $165.23M(-9.3%) |
| Mar 2022 | - | $182.27M(-9.7%) |
| Dec 2021 | $201.88M(-17.4%) | $201.88M(-5.3%) |
| Sep 2021 | - | $213.12M(-5.3%) |
| Jun 2021 | - | $224.97M(-5.2%) |
| Mar 2021 | - | $237.22M(-2.9%) |
| Dec 2020 | $244.34M(-11.8%) | $244.34M(-3.7%) |
| Sep 2020 | - | $253.79M(-3.1%) |
| Jun 2020 | - | $261.95M(-2.4%) |
| Mar 2020 | - | $268.28M(-3.2%) |
| Dec 2019 | $277.12M | $277.12M(-2.2%) |
| Sep 2019 | - | $283.49M(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $288.35M(-2.1%) |
| Mar 2019 | - | $294.57M(-1.1%) |
| Dec 2018 | $297.75M(+2111.5%) | $297.75M(-1.4%) |
| Sep 2018 | - | $302.05M(+115.2%) |
| Jun 2018 | - | $140.36M(+93.3%) |
| Mar 2018 | - | $72.63M(+439.5%) |
| Dec 2017 | $13.46M(+67.4%) | $13.46M(+504.9%) |
| Sep 2017 | - | $2.23M(-66.2%) |
| Jun 2017 | - | $6.59M(-12.7%) |
| Mar 2017 | - | $7.55M(-6.2%) |
| Dec 2016 | $8.04M(-7.8%) | $8.04M(-21.3%) |
| Sep 2016 | - | $10.22M(-20.1%) |
| Jun 2016 | - | $12.79M(+121.6%) |
| Mar 2016 | - | $5.77M(-33.9%) |
| Dec 2015 | $8.72M(-139.4%) | $8.72M(-34.3%) |
| Sep 2015 | - | $13.27M(-23.7%) |
| Jun 2015 | - | $17.39M(-162.5%) |
| Mar 2015 | - | -$27.84M(+25.8%) |
| Dec 2014 | -$22.13M(+8730.2%) | -$22.13M(-4.9%) |
| Jun 2014 | - | -$23.26M(+4759.6%) |
| Mar 2014 | - | -$478.60K |
| Dec 2013 | -$250.60K(+137.8%) | - |
| Dec 2012 | -$105.40K | - |
FAQ
- What is Viking Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Viking Therapeutics?
- What is Viking Therapeutics annual shareholders equity year-on-year change?
- What is Viking Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Viking Therapeutics?
- What is Viking Therapeutics quarterly shareholders equity year-on-year change?
What is Viking Therapeutics annual stockholders equity?
The current annual shareholders equity of VKTX is $880.28M
What is the all time high annual shareholders equity for Viking Therapeutics?
Viking Therapeutics all-time high annual stockholders equity is $880.28M
What is Viking Therapeutics annual shareholders equity year-on-year change?
Over the past year, VKTX annual stockholders equity has changed by +$531.86M (+152.65%)
What is Viking Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VKTX is $846.92M
What is the all time high quarterly shareholders equity for Viking Therapeutics?
Viking Therapeutics all-time high quarterly stockholders equity is $933.89M
What is Viking Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VKTX quarterly stockholders equity has changed by -$86.97M (-9.31%)